Bioterrorism Week articles from November 2003

Bioterrorism Week archives from November 2003

Voluntary smallpox vaccination program unlikely to provide optimal coverage.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- A voluntary smallpox vaccination program is unlikely to provide optimal coverage of the population. According to a study from Canada and the United States, "The recent threat of bioterrorism has...

Instrument rapidly detects cyanide poisoning.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- The U.S. National Institutes of Health (NIH) has awarded a $75,000 grant to University of Wyoming (UW) chemists for the development of a new portable instrument that rapidly detects the presence of...

Alliance will focus on infectious, parasitic disease research.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Invest U.K., the British government's worldwide inward investment agency, announced that the U.S. Centers for Disease Control and Prevention (CDC) has signed a formal memorandum of understanding with...

Ecology of infectious diseases grants awarded.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Two government agencies have announced funding for six projects under the Ecology of Infectious Diseases (EID) program, the fourth year of funding in this multiyear effort. The joint U.S. National...

Human blast lung injury due to explosives creates lung emboli even in fat.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Human lung injury due to explosive detonation creates lung emboli even in fat, and must be considered a risk in survivors, too. "The objective of this autopsy-based study was to investigate the...

Ibis program receives $6 million grant from the CDC.
November 3, 2003... 2003 NOV 3 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) confirmed that its Ibis program received a 3-year grant for up to $6 million from the U.S. Centers for Disease Control and Prevention (CDC) to develop and apply its...

Anti-anthrax antibody protects and treats anthrax infection in animal model.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) announced that its fully human antibody against anthrax, MDX-1303, protected against inhalation anthrax at a dose 10-fold lower than previously tested in rabbits treated with the...

CDC releases draft version of new SARS plan.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- The U.S. Centers for Disease Control and Prevention (CDC) has posted the working draft version of its "Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory...

Saliva spits out information on chemical exposure.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Home testing of saliva to measure personal hormone levels is gaining popularity, with dozens of companies offering do-it-yourself, mail-in test kits. Battelle scientists at the U.S. Department of...

Biopharm company to gain commercial rights to anthrax vaccine candidate.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) has entered into a license agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) that gives VaxGen exclusive, worldwide rights to develop and...

NIH grant to fund development of DNA delivery of vaccines.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Robert G. Kramer, president of BioPort Corporation, announced that the manufacturer of the only U.S. Food and Drug Administration (FDA) approved anthrax vaccine will team with Therapeutic Systems...

Postal workers sue Bayer, hospitals over antibiotic.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- A group of U.S. Postal Service workers has filed a lawsuit against the manufacturer of an antibiotic they took during the anthrax scare 2 years ago. The lawsuit filed in Superior Court in Camden,...

SBIR grant from NIAID awarded to expand development of antibodies.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Avanir Pharmaceuticals (AVN) announced the award of a $100,000 grant through the Small Business Innovative Research (SBIR) program of the National Institute of Allergy and Infectious Diseases (NIAID)...

$14M NIH grant awarded to develop chemokine-based immunomodulators.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- ChemoCentryx, Inc., announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, has awarded the company a $14 million grant to...

U.S. Air Force awards task order for construction of biological laboratory.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Versar, Inc., (VSR) has been awarded a task order valued at approximately $750,000 from the U.S. Air Force for the construction of an epidemic outbreak surveillance advanced diagnostics laboratory at...

First LSTAT platform bearing the CE mark shipped to Finnish military.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Integrated Medical Systems, Inc., has shipped the first LSTAT Model G5 patient-care platform bearing the CE mark, clearing the marketing, sale, and use of the LSTAT platform throughout the European...

Intel and Fred Hutchinson to explore the use of nanotechnology tools.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Intel Corp. and the Fred Hutchinson Cancer Research Center have announced a collaborative research effort to apply Intel's expertise in nanotechnology to develop improved methods of studying,...

Alliance targets development of hyperimmune specific for SARS.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Cangene Corporation (CNJ) announced that it has signed a research and development contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes...

Orthopoxviruses detected using microarrays of immobilized oligonucleotides.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- Researchers report the detection and discrimination of orthopoxviruses using microarrays of immobilized oligonucleotides. "Variola virus (VARV), causing smallpox, is a potential biological weapon....

Homeopathic remedy for arsenic poisoning explored.
November 10, 2003... 2003 NOV 10 - (NewsRx.com & NewsRx.net) -- A homeopathic remedy made from arsenic oxide could ease the suffering of the hundreds of millions of people at risk from arsenic poisoning worldwide. Research published in BMC Complementary and...

Anthrax vaccine confers protection against both bacilli and toxins.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- A dually active anthrax vaccine conferred protection against both bacilli and toxins. According to a study from the United States, "Systemic anthrax is caused by unimpeded bacillar replication and...

Can immunization programs be done efficiently and effectively?
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- Speculation about the potential for a smallpox attack has led to concerns about the ability of the public health system to vaccinate a large portion of the population against the disease. In an...

Completion of breadboard prototype design reported.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- Centrex, Inc., (CNEX) announced that Stratos Product Development, LLC, has notified the company of the completion of the breadboard prototype design specifications and electromechanical detail design...

Nano-Proprietary announces improved carbon nanotube-based biosensor.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- Nano-Proprietary, Inc., (NNPP), through its subsidiary, Applied Nanotech, Inc., (ANI) announced the successful demonstration of an improved biosensor using carbon nanotubes (CNTs). The new...

TeleScience announces contract award.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- TeleScience International, Inc., a wholly owned subsidiary of Medical Staffing Solutions, Inc., (MSSI) announced that its homeland security division has been named as one of approximately 10 awardees...

$5.9M research grant from NIH to be used for bioterror defense.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- Coley Pharmaceutical Group, Inc., announced that it has been awarded a $5.88M grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of...

Novel immunosuppressive regimens may result from closer study of lymphoid organ.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- Novel immunosuppressive regimens may result from a better understanding of lymphoid organ function. According to a study from the United States, "As we travel into a new century, confronted with...

NIAID funding granted for new biodefence project.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- Cangene Corporation (CNJ) announced that it has received funding from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), for a...

Simulation of flu-like illnesses draws nuanced picture of public health threats.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- A new computational method for simulating the spread of flu-like illnesses like SARS (severe acute respiratory syndrome) that is being developed by a University at Buffalo geographer may provide policy...

Postexposure vaccination is effective for prevention of smallpox.
November 17, 2003... 2003 NOV 17 - (NewsRx.com & NewsRx.net) -- Postexposure vaccination is effective for prevention of smallpox, especially in individuals who have been vaccinated previously. "We estimated the effectiveness of postexposure smallpox...

Prevention and treatment of bacterial bioterrorism agent diseases reviewed.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- Researchers reviewed the prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents in a recent issue of Drug Discovery Today. "There is general consensus that...

Study will address potential emergency measures for bioterrorism.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- Little attention has been given to preparing residents and health care providers in America's sparsely populated areas for possible bioterrorist acts, even though experts warn the risks such incidents...

$30M available for bioterrorism preparation.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- On December 8, 2003, the Health Resources and Service Administration, under the U.S. Department of Health and Human Services (HHS), is issuing a Request for Application to make an additional $30...

SBIR bio-terrorism grant awarded to develop anthrax septicemia treatment.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- Adenosine Therapeutics, LLC announced the award of a phase I Small Business Innovation Research (SBIR) grant from the U.S. Department of Defense. The grant, entitled "A2A Adenosine Agonists as...

Applied epidemiology and training improves response to bioterrorism.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- Applied epidemiology and training programs improve the early warning and response to infectious diseases and bioterrorism. "In many ministries of health, applied epidemiology and training programs...

Chronic fatigue, fibromyalgia, Gulf War syndromes have mycoplasmas in common.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- Chronic fatigue, fibromyalgia, Gulf War syndromes have higher prevalence of mycoplasmas in common; it is unclear if it is causative, but clearance with doxycycline can resolve disease. "Chronic...

IGEN reports second-quarter results.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- IGEN International, Inc.'s, (IGEN) revenues for the second quarter ended September 30, 2003, increased to $40.4 million, compared to $13.4 million for the same period last year. Revenues for the 6...

Team creates vaccine-evading virus.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- A research team has created a genetically engineered mousepox virus designed to evade vaccines, highlighting the deadly potential of biotechnology and bioterrorism. The team at St. Louis...

Poxviruses show promise as vaccine vectors.
November 24, 2003... 2003 NOV 24 - (NewsRx.com & NewsRx.net) -- Poxviruses show promise as vaccine vectors. "The discovery of Jenner in 1798 founded the science of immunology and eventually led to smallpox eradication from the earth in 1980 after a world-wide...